Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

Braxia Scientific Secures Approval for Direct Billing Insurance on Ketamine Treatments for Veterans Affairs Canada Clients

PR Newswire July 20, 2021

Braxia Scientific to Discuss Psychiatric Treatment Discovery and Development with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021

PR Newswire July 7, 2021

Braxia Scientific Announces Participation at PSYCH Investor Summit on July 7, 2021

PR Newswire July 6, 2021

Braxia Scientific Launches Psilocybin-Assisted Clinical Therapy Training Program to Develop New Generation of Qualified Physicians, Psychotherapists and Psychologists for Mental Health

PR Newswire June 29, 2021

/R E P E A T -- Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/

Canada NewsWire June 17, 2021

Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression

Canada NewsWire June 17, 2021

/R E P E A T -- Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021/

Canada NewsWire June 16, 2021

Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021

Canada NewsWire June 16, 2021

BRAXF Final Deadline Today: Rosen, A Top Ranked Law Firm, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important Deadline Today in Securities Class Action - BRAXF, SHRMF

Newsfile June 9, 2021

American Journal of Psychiatry Publishes International Ketamine and Esketamine Treatment Guidance Led by Braxia Scientific CEO Dr. Roger Mcintyre

Canada NewsWire June 9, 2021

BRAXF Final Deadline Tomorrow: Rosen, Leading Trial Attorneys, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important June 9 Deadline in Securities Class Action - BRAXF, SHRMF

Newsfile June 8, 2021

BRAXF FINAL DEADLINE WEDNESDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important June 9 Deadline in Securities Class Action - BRAXF, SHRMF

GlobeNewswire June 7, 2021

BRAXF FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important June 9 Deadline in Securities Class Action - BRAXF, SHRMF

PR Newswire June 5, 2021

Braxia Scientific Appoints Dr. David Greenberg to Board of Directors

PR Newswire May 31, 2021

/R E P E A T -- Braxia Scientific Announces Symbol Change on OTC markets to "BRAXF"/

Canada NewsWire May 21, 2021

Braxia Scientific Announces Symbol Change on OTC Markets to "BRAXF"

Canada NewsWire May 20, 2021

/R E P E A T -- Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants/

Canada NewsWire May 20, 2021

Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants

Canada NewsWire May 20, 2021

Braxia Scientific Opens First Ketamine Therapy Clinic in Quebec; Enters Joint Venture with Neurotherapy Montreal, A Leading Brain Injury Solutions Clinic for Adults and Children

Canada NewsWire May 13, 2021

Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders

Canada NewsWire May 7, 2021